<b>Etiology, Complications, and Outcomes of Liver Cirrhosis in Patients Referred to or Hospitalized at Imam Khomeini Hospital, Ardabil, Iran (2019–2024): A Cross</b><b>‑</b><b>Sectional Study</b>
PDF

Keywords

Non‑alcoholic steatohepatitis (NASH
Etiology
Liver cirrhosis
Hepatitis B

How to Cite

1.
Etiology, Complications, and Outcomes of Liver Cirrhosis in Patients Referred to or Hospitalized at Imam Khomeini Hospital, Ardabil, Iran (2019–2024): A Cross‑Sectional Study. etmhrj [Internet]. 2026 Aug. 31 [cited 2026 Nov. 19];1(1):9-15. Available from: https://etmhrj.ir/journal/article/view/7

Abstract

Introduction: Liver cirrhosis is a progressive chronic liver disease characterized by fibrosis and architectural distortion, leading to complications such as portal hypertension, ascites, encephalopathy, and esophageal varices. As the prevalence of viral and metabolic liver diseases changes globally, understanding regional etiological patterns is essential.

Methods: In this retrospective cross-sectional study, 200 patients with confirmed liver cirrhosis were evaluated using hospital records. Demographic characteristics, substance use, etiology, complications, and hospitalization outcomes were analyzed using SPSS v26. Statistical significance was defined as p<0.05.

Results: Nonalcoholic steatohepatitis (NASH) was the most common cause of cirrhosis (44.1%), followed by hepatitis B (20.6%), autoimmune hepatitis/PSC (10.8%), alcoholic liver disease (9.3%), and hepatitis C (8.8%). Wilson disease and cardiac cirrhosis were rare. Etiology differed significantly across age groups (p=0.003), but not by sex or clinical outcome. Portal hypertension was the most frequent complication (≈94%), followed by ascites (34.8%) and esophageal varices (26.5%). Overall mortality was 19%, while hospitalization duration and frequency did not vary significantly among etiological groups.

Conclusion: NASH has become the leading cause of liver cirrhosis in this population, reflecting the growing impact of metabolic disorders. These findings emphasize the importance of preventive strategies, lifestyle modification, and effective management of metabolic risk factors to reduce the burden of cirrhosis.

PDF

References 37

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 Melika Mousavi, Atabak Sedigh-Namin, Somaieh Matin, Shafagh Aliasgarzadeh, nazli javaheri (Author)